The DEA recently announced that CBD oil is now specifically named as a Schedule I drug.
CBD, cannabidiol, is a non-psychoactive compound found in marijuana. CBD can be used to treat epilepsy, anxiety and more. Marijuana is already a Schedule I drug, so this doesn’t really change anything, as John Hudak of the Brookings Institute explained on Twitter.
Breaking: CBD has never been anything but a Schedule I substance. DEA did not reschedule it today & anyone who says so is wholly misinformed. — John Hudak (@JohnJHudak) December 14, 2016
However, many responded to the announcement with fury and alarm. Many in the marijuana industry claimed this unfairly targets an important medical compound, but the DEA says it’s just changing some language so it can better track extracts. From Motherboard:
“Chuck Rosenberg, DEA Acting Administrator, described the new code as a way for the DEA to ‘track quantities of this material separately from quantities of marijuana,’ in order for the US to be compliant with international drug-control treaties.”
Motherboard explains that it was generally accepted, perhaps outside the legal world, that selling CBD derived from hemp was lawful. This change in language clarifies that that is not the case.
“For practical purposes, all extracts that contain CBD will also contain at least small amounts of other cannabinoids,” said Rosenberg.
Source: The 420 Times
View Original Post